The Insight Partners published latest research report on “Travel Vaccines Market Size Report, Share, Trends & Growth Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Application”,
The Insight Partners published latest research report on “Travel Vaccines Market Size Report, Share, Trends & Growth Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Application”, the global market size is projected to reach USD 5,914.22 million by 2028 from USD 3,078.94 million in 2021. It is estimated to grow at a CAGR of 9.8% from 2021 to 2028.
Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00007439
Travel vaccines, also called travel immunizations, are shots travellers can get before visiting certain areas of the world that help protect them from serious illnesses. Vaccinations work by exposing the body to germs or parts of germs of the disease it will protect against. Travel vaccines are safe, effective ways to help protect travellers from bringing home more than they bargained for. These vaccines are recommended to provide protection against diseases endemic to the country of origin or of destination. They are intended to protect travellers and to prevent disease spread within and between countries. Some countries require proof of vaccination for travellers wishing to enter or exit the country.
Growth Strategies by the Key Players Operating in the Travel Vaccines Market:
Dec 2021 - Emergent BioSolutions Inc. announced the first participant dosed in its phase 1 study, EBS-UFV-001, evaluating the safety, tolerability, and immunogenicity of the company’s investigational universal influenza vaccine candidate. The current version of the influenza vaccine candidate contains multiple components intended to induce broad and supra-seasonal immunity against influenza A viruses.
Dec 2021 - GlaxoSmithKline (GSK) plc welcomed the decision of the Gavi Board to provide funding for the procurement and introduction of malaria vaccines into routine child immunisation programmes in Gavi eligible countries. The announcement followed shortly after WHO recommendation for the broader use of GSK’s RTS,S/AS01e to reduce childhood illness and deaths from malaria in children living in sub-Saharan Africa and other regions.
Oct 2020 - Merck new clinical and epidemiological data from its broad infectious diseases and vaccines program was presented at IDWeek 2020. Clinical data include new subgroup analyses from the Phase 3 RESTORE-IMI 2 trial evaluating the safety and efficacy of RECARBRIO, and a new pooled analysis of the safety and efficacy of PIFELTRO (doravirine) or DELSTRIGO in adults 50 years of age and older living with HIV-1 who are treatment-naïve.
Dec 2019 - GlaxoSmithKline plc completed the divestment of travel vaccines Rabipur for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic. GSK received an upfront payment of USD 348 million.
Directly Purchase Premium Copy of Travel Vaccines Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPRE00007439
Global Travel Vaccines Market Share Report, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 3,078.94 million in 2021 |
| Market Size Value by | USD 5,914.22 million by 2028 |
| Growth rate | CAGR of 9.8% from 2021 to 2028. |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
| No. of Pages | 198 |
| No. of Tables | 60 |
| No. of Charts & Figures | 104 |
| Historical data available | Yes |
| Segments covered | Product and Application |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | GlaxoSmithKline plc, Merck & Co., Inc., Sanofi, Novartis AG, Pfizer Inc., Dynavax Technologies, Emergent BioSolutions Inc., Abbott, Bharat Biotech, Valneva SE |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 198 pages with 60 list of tables & 104 list of figures from the report, “Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, DPT, Yellow Fever, Typhoid, Japanese Encephalitis, Measles Mumps & Rubella, Rabies, Polio, Influenza, Varicella & Shingles, Cholera, and Others) and Application (Domestic Travel and Outbound Travel))” in detail along with the table of contents: https://www.theinsightpartners.com/reports/travel-vaccines-market
The COVID-19 pandemic has created both a public health crisis and an economic crisis. The pandemic adversely affected an unbelievable percentage of the population since the first quarter of 2020. The regions saw a steep decline in travel, both domestic and international. The decline in travel was primarily due to various regulations and mandates imposed by the governments to prevent the spread of the COVID-19 virus. This consequently led to the decrease in the demand for travel vaccines, resulting in a consequent decline in the travel vaccine market growth.
Vaccination is necessary against the diseased mentioned in the US Department of Health & Human Services (HHS), such as chickenpox, cholera, COVID-19, diphtheria, influenza, Hepatitis A, Hepatitis B, Haemophilus influenzae type B, human papillomavirus, Japanese encephalitis, measles, meningococcal, mumps, pneumococcal, polio, rabies, rotavirus, rubella, shingles, tetanus, typhoid fever, whooping cough, and yellow fever, depending on the traveling country. Concerns regarding the spread of regional diseases across nations are boosting the demand for travel vaccines, thereby driving the market. Additionally, the rising trend of emergence and re-emergence of infectious diseases and their spread through travel is expected to drive the growth of the travel vaccines market.
The travel and tourism industry has seen robust growth in the recent decades with improving disposable income of individuals, better traveling routes, a variety of transportation methods, and more. Tourism has also increased with travellers looking to explore human behaviour and cultures by exploration of different cultures, traditions, spiritualism, rural and ethnic living. This data is substantiated by a recent survey conducted by The Millennial Travel Study by Skyscanner. In the survey, over ~1,000 millennials (aged 18-35) were quizzed on factors, such as their preferred destination, mode of travel, and interests. The survey showed that four-fifths of respondents preferred traveling to international destinations over domestic ones. The survey also noted European destinations were one of the most sought-after regions among travellers of all age groups, followed by the US and New Zealand.
Additionally, statistics from Our World in Data collect data from the World Tourism Organization showed increased tourism in various regions in 2019, such as the European Union saw ~966.44 million arrivals, North America saw ~200 million arrivals, and The Middle East & North Africa saw ~128 million arrivals. Furthermore, arrivals in France stood at 212 million in 2019, while other European countries such as Spain saw 126.17 million arrivals in 2019. Also, in 2019, the international number of arrivals stood at 2.403 billion. By region, the European Union saw the highest international arrivals of an estimated 966.44 million and East Asia & Pacific saw international arrivals of 487.08 million. The estimated expenditure for international tourism stood at an estimated US$ 1.439 billion. While the COVID-19 pandemic hugely disrupted this trend, the rollout of anti-COVID-19 vaccinations and COVID-19 regulations for safe traveling is expected to aid the normalization of tourism and travel. The pandemic has led to an emphasis on immunizations for travelers to avoid the spread of infections. Various countries have their own policies to protect traveling citizens from travel-associated infections. For instance, in the UK, the National Health Service (NHS) organizes routine immunization or vaccination drives for its citizens. If a person is traveling outside the UK, he/she needs to get vaccinated to prevent infectious diseases such as hepatitis A, typhoid, measles, mumps, yellow fever, among others. Similarly, in Saudi Arabia, travelers coming from various countries for Hajj and Umrah pilgrimages are required to show proof of vaccination for meningitis and seasonal influenza. Various countries require mandatory vaccination proofs documented on an International Certificate of Vaccination or Prophylaxis (ICVP). Vaccination is necessary against the diseased mentioned in the US HHS (Department of Health & Human Services) such as chickenpox, cholera, COVID-19, diphtheria, influenza, Hepatitis A, Hepatitis B, Haemophilus influenzae type B, human papillomavirus, Japanese encephalitis, measles, meningococcal, mumps, pneumococcal, polio, rabies, rotavirus, rubella, shingles, tetanus, typhoid fever, whooping cough, and yellow fever, depending on the traveling country. The concern regarding the spread of regional diseases across nations is boosting the demand for travel vaccines.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Vaccines Market to 2027- Global Analysis and Forecasts
Inactivated Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Meningococcal Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis
Veterinary Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/travel-vaccines-market